ArticleNeurology(R) neuroimmunology & neuroinflammation2024

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Wei Z Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.